search for




 

Editorial commentary: is biologic augmentation beneficial in anterior cruciate ligament reconstruction?
Arthrosc Orthop Sports Med 2024;11:36-38
Published online May 1, 2024;  https://doi.org/10.14517/aosm24003
© 2024 Korean Arthroscopy Society and Korean Orthopedic Society for Sports Medicine.

Jae Hyeok Cheon, Hong Yeol Yang

Department of Orthopedic Surgery, Chonnam National University Bitgoeul Hospital, Chonnam National University Medical School, Gwangju, Korea
Correspondence to: Hong Yeol Yang, https://orcid.org/0000-0001-8730-9040
Department of Orthopedic Surgery, Chonnam National University Bitgoeul Hospital, Chonnam National University Medical School, 80 Deongnam-gil, Nam-gu, Gwangju 61748, Korea. Tel: +82-62-670-9475, Fax: +82-62-670-9475, E-mail: stephano.h.yang@gmail.com
Received April 9, 2024; Revised April 11, 2024; Accepted April 11, 2024.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Surgical reconstruction for anterior cruciate ligament (ACL) injuries has been demonstrated to be a reliable and effective treatment that provides satisfactory results. Despite its successful outcomes, bone tunnel enlargement is a concerning complication following ACL reconstruction (ACLR) that has been reported over several years. Various biologic augmentation techniques have been implemented to address this concern. Recently, fibrin clot augmentation has been employed to promote bone and tendon healing; despite its lack of clinical relevance, it was ultimately found to reduce tunnel widening following ACL reconstruction. In the setting of biologic augmentation for ACLR, a thorough assessment of various factors such as efficacy, expense, and possible risks is crucial. Additional clinical studies are needed to elucidate whether current and emerging bioaugmentation techniques are truly beneficial for patients requiring ACLR.
Keywords : Biologic augmentation; Fibrin clot; Tunnel widening; Anterior cruciate ligament reconstruction; Anterior cruciate ligament injuries
References
  1. Mall NA, Chalmers PN, Moric M, et al. Incidence and trends of anterior cruciate ligament reconstruction in the United States. Am J Sports Med 2014;42:2363-70.
    Pubmed CrossRef
  2. Meredick RB, Vance KJ, Appleby D, Lubowitz JH. Outcome of single-bundle versus double-bundle reconstruction of the anterior cruciate ligament: a meta-analysis. Am J Sports Med 2008;36:1414-21.
    Pubmed CrossRef
  3. Arnoczky SP, Warren RF, Ashlock MA. Replacement of the anterior cruciate ligament using a patellar tendon allograft. An experimental study. J Bone Joint Surg Am 1986;68:376-85.
    Pubmed CrossRef
  4. Surer L, Yapici C, Guglielmino C, van Eck CF, Irrgang JJ, Fu FH. Fibrin clot prevents bone tunnel enlargement after ACL reconstruction with allograft. Knee Surg Sports Traumatol Arthrosc 2017;25:1555-60.
    Pubmed CrossRef
  5. LaPrade RF, Dragoo JL, Koh JL, Murray IR, Geeslin AG, Chu CR. AAOS research symposium updates and consensus: biologic treatment of orthopaedic injuries. J Am Acad Orthop Surg 2016;24:e62-78.
    Pubmed KoreaMed CrossRef
  6. Zhang ZZ, Luo H, Zhang HZ, et al. H-plasty repair technique improved tibiofemoral contact mechanics after repair for adjacent radial tears of posterior lateral meniscus root: a biomechanical study. Arthroscopy 2021;37:2204-16.e2.
    Pubmed CrossRef
  7. Saltzman BM, Habet NA, Rao AJ, et al. Biomechanical evaluation of an all-inside posterior medial meniscal root repair technique via suture fixation to the posterior cruciate ligament. Arthroscopy 2020;36:2488-97.e6.
    Pubmed CrossRef
  8. Kurzweil P, Krych AJ, Anz A, et al. Favorable reoperation rate at 2 years following repair of horizontal cleavage tears using an all suture-based technique: a prospective, multicenter trial. Arthrosc Sports Med Rehabil 2021;3:e773-80.
    Pubmed KoreaMed CrossRef
  9. Yoon KH, Park JY, Kwon YB, Lee YJ, Kim EJ, Kim SG. Inside-out repair of the meniscus in concomitant anterior cruciate ligament reconstruction: absorbable versus nonabsorbable sutures. Arthroscopy 2020;36:1074-82.
    Pubmed CrossRef
  10. Cristiani R, Parling A, Forssblad M, Edman G, Engström B, Stålman A. Meniscus repair does not result in an inferior short-term outcome compared with meniscus resection: an analysis of 5,378 patients with primary anterior cruciate ligament reconstruction. Arthroscopy 2020;36:1145-53.
    Pubmed CrossRef
  11. Yang BW, Liotta ES, Paschos N. Outcomes of meniscus repair in children and adolescents. Curr Rev Musculoskelet Med 2019;12:233-8.
    Pubmed KoreaMed CrossRef
  12. Tian B, Zhang M, Kang X. Strategies to promote tendon-bone healing after anterior cruciate ligament reconstruction: present and future. Front Bioeng Biotechnol 2023;11:1104214.
    Pubmed KoreaMed CrossRef
  13. Ritchie JR, Miller MD, Bents RT, Smith DK. Meniscal repair in the goat model. The use of healing adjuncts on central tears and the role of magnetic resonance arthrography in repair evaluation. Am J Sports Med 1998;26:278-84.
    Pubmed CrossRef
  14. Ra HJ, Ha JK, Jang SH, Lee DW, Kim JG. Arthroscopic inside-out repair of complete radial tears of the meniscus with a fibrin clot. Knee Surg Sports Traumatol Arthrosc 2013;21:2126-30.
    Pubmed CrossRef
  15. Hensler D, Illingworth KD, Musahl V, et al. Does fibrin clot really enhance graft healing after double-bundle ACL reconstruction in a caprine model? Knee Surg Sports Traumatol Arthrosc 2015;23:669-79.
    Pubmed CrossRef


May 2024, 11 (1)